A federal judge has ruled that hundreds of Fosamax femur fracture lawsuits are preempted by federal law because the FDA rejected a proposed warning label change.
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
A new study reveals that Fosamax and similar osteoporosis drugs failed to provide any benefits in preventing hip fractures after seven years of use.
A new study warns that Fosamax and similar drugs greatly increase the risk of atypical femur fractures after more than five years of use.
A judge is ordering plaintiffs to show cause why remaining Fosamax femur fracture lawsuits in the federal MDL should not be dismissed, after rejecting failure to warn arguments that the…
A new study adds to evidence that some osteoporosis drugs can lead to rare thigh bone breaks.
A federal judge has ordered parties involved in Fosamax femur fracture lawsuits into mediation to hopefully reach a Fosamax fracture settlement.
A new study provides new evidence linking the bone drug Fosamax to an increased risk of jaw bone death, involving a rare condition known as osteonecrosis of the jaw.
The judge presiding over all Fosamax femur fracture lawsuits has granted summary judgment in a lawsuit over the 2010 warning update, which could put hundreds of additional lawsuits in jeopardy…
A federal judge has ruled that some Fosamax fracture cases are preempted by federal law and has thrown them out.
